ArticleVaccines2026

Preclinical Safety Evaluation of a Replication-Defective Canine Adenovirus Type 2 Vector-Based SARS-CoV-2 Vaccine Candidate in Murine Models.

Denis Omara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.